drugset / Trial / NCT01409031
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase 2
Terminated
3 enrolled
University of Colorado, Denver
Ann & Robert H Lurie Children's Hospital of Chicago · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabState University of New York at Buffalo · collabUniversity of Alabama at Birmingham · collabUniversity of Utah · collabVanderbilt University · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether intravenous sildenafil reduces pulmonary artery pressure and improves oxygenation in near-term and term infants with persistent pulmonary hypertension.
Timeline
- Start
- 2011-07
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 1.6 mg/kg | Intravenous |